HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pediatric brainstem gangliogliomas show BRAF(V600E) mutation in a high percentage of cases.

Abstract
Brainstem gangliogliomas (GGs), often cannot be resected, have a much poorer prognosis than those located in more common supratentorial sites and may benefit from novel therapeutic approaches. Therapeutically targetable BRAF c.1799T>A (p.V600E) (BRAF(V600E) ) mutations are harbored in roughly 50% of collective GGs taken from all anatomical sites. Large numbers of pediatric brainstem GGs, however, have not been specifically assessed and anatomic-and age-restricted assessment of genetic and biological factors are becoming increasingly important. Pediatric brainstem GGs (n = 13), non-brainstem GGs (n = 11) and brainstem pilocytic astrocytomas (PAs) (n = 8) were screened by standard Sanger DNA sequencing of BRAF exon 15. Five of 13 (38%) pediatric GG harbored a definitive BRAF(V600E) mutation, with two others exhibiting an equivocal result by this method. BRAF(V600E) was also seen in five of 11 (45%) non-brainstem GGs and one of eight (13%) brainstem PAs. VE1 immunostaining for BRAF(V600E) showed concordance with sequencing in nine of nine brainstem GGs including the two cases equivocal by Sanger. The equivocal brainstem GGs were subsequently shown to harbor BRAF(V600E) using a novel, more sensitive, RNA-sequencing approach, yielding a final BRAF(V600E) mutation frequency of 54% (seven of 13) in brainstem GGs. BRAF(V600E) -targeted therapeutics should be a consideration for the high percentage of pediatric brainstem GGs refractory to conventional therapies.
AuthorsAndrew M Donson, Bette K Kleinschmidt-DeMasters, Dara L Aisner, Lynne T Bemis, Diane K Birks, Jean M Mulcahy Levy, Amy A Smith, Michael H Handler, Nicholas K Foreman, Sarah Z Rush
JournalBrain pathology (Zurich, Switzerland) (Brain Pathol) Vol. 24 Issue 2 Pg. 173-83 (Mar 2014) ISSN: 1750-3639 [Electronic] Switzerland
PMID24238153 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 International Society of Neuropathology.
Chemical References
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
Topics
  • Adolescent
  • Brain Stem Neoplasms (genetics, pathology)
  • Child
  • Child, Preschool
  • Exons
  • Female
  • Ganglioglioma (genetics, pathology)
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Mutation
  • Proto-Oncogene Proteins B-raf (genetics)
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: